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Predictors of Medication Nonadherence Differ among Black and White Patients
with Heart Failure
Abstract
Heart failure (HF) is a global public health problem, and outcomes remain poor, especially among ethnic
minority populations. Medication adherence can improve heart failure outcomes but is notoriously low.
The purpose of this secondary analysis of data from a prospective cohort comparison study of adults
with heart failure was to explore differences in predictors of medication nonadherence by racial group
(Black vs. White) in 212 adults with heart failure. Adaptive modeling analytic methods were used to model
HF patient medication nonadherence separately for Black (31.7%) and White (68.3%) participants in order
to investigate differences between these two racial groups. Of the 63 Black participants, 33.3% had low
medication adherence, compared to 27.5% of the 149 White participants. Among Blacks, 16 risk factors
were related to adherence in bivariate analyses; four of these (more comorbidities, lower serum sodium,
higher systolic blood pressure, and use of fewer activities compensating for forgetfulness) jointly
predicted nonadherence. In the multiple risk factor model, the number of risk factors in Black patients
ranged from 0 to 4, and 76.2% had at least one risk factor. The estimated odds ratio for medication
nonadherence was increased 9.34 times with each additional risk factor. Among White participants, five
risk factors were related to adherence in bivariate analyses; one of these (older age) explained the
individual effects of the other four. Because Blacks with HF have different and more risk factors than
Whites for low medication adherence, interventions are needed that address unique risk factors among
Black patients with HF.
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Abstract
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Heart failure (HF) is a global public health problem, and outcomes remain poor, especially among
ethnic minority populations. Medication adherence can improve heart failure outcomes but is
notoriously low. The purpose of this secondary analysis of data from a prospective cohort
comparison study of adults with heart failure was to explore differences in predictors of
medication nonadherence by racial group (Black vs. White) in 212 adults with heart failure.
Adaptive modeling analytic methods were used to model HF patient medication nonadherence
separately for Black (31.7%) and White (68.3%) participants in order to investigate differences
between these two racial groups. Of the 63 Black participants, 33.3% had low medication
adherence, compared to 27.5% of the 149 White participants. Among Blacks, 16 risk factors were
related to adherence in bivariate analyses; four of these (more comorbidities, lower serum sodium,
higher systolic blood pressure, and use of fewer activities compensating for forgetfulness) jointly
predicted nonadherence. In the multiple risk factor model, the number of risk factors in Black
patients ranged from 0 to 4, and 76.2% had at least one risk factor. The estimated odds ratio for
medication nonadherence was increased 9.34 times with each additional risk factor. Among White
participants, five risk factors were related to adherence in bivariate analyses; one of these (older
age) explained the individual effects of the other four. Because Blacks with HF have different and
more risk factors than Whites for low medication adherence, interventions are needed that address
unique risk factors among Black patients with HF.

Author Manuscript
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Heart failure (HF) is a global public health issue, with a prevalence of over 5.7 million cases
in the United States (US; Mozaffarian et al., 2014) and over 23 million cases worldwide
(Bui, Horwich, & Fonarow, 2011). In the US, the highest prevalence of HF is in Blacks
(3.6%), followed by Whites (2.4%) and Hispanics (2.3%; Heidenreich et al., 2013). Overall,
1 in 9 deaths is attributed to HF (Mozaffarian et al., 2014). Ethnic minority patients have a
2.5 times greater risk of HF-related mortality, which is especially pronounced for Black
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males (81.9 national death rate per 100,000 people, compared to 62.1 for White males, and
58.7 for Black females compared to 43.2 for White females; Bahrami et al., 2008).
Heart failure is a major contributor to the cost of health care, predominately because of
hospitalizations (Heidenreich et al., 2013). Over the last thirty years, hospitalizations for HF
have nearly tripled to more than 1 million in 2006; establishing HF as the most common
cause for hospitalization in the Medicare population (Koelling, Johnson, Cody, & Aaronson,
2005). Compared to Whites, the likelihood of a HF hospitalization is estimated to be 1.5
times greater among Blacks and 1.2 times greater among Hispanics (Brown, Haldeman,
Croft, Giles, & Mensah, 2005).

Author Manuscript

The reason for this health disparity is complex. Medication nonadherence is one important
contributor to hospitalization in patients with HF (Riegel & Knafl, 2013). In addition,
Blacks are more likely than Whites to have diabetes, hypertension and obesity, which
increase the risk of HF, complicate management and contribute to poorer outcomes
(Schocken et al., 2008). Low socioeconomic status, which is more common in ethnic
minority populations, is associated with poor HF outcomes, presumably due to barriers to
access and utilization of health care services (Schocken et al., 2008). But surprisingly little
research has explored this disparity, so the purpose of this study was to delve further into
medication adherence to determine if differences exist that could help to explain the
disparity in HF outcomes among White and Black patients.

Medication Adherence in Heart Failure

Author Manuscript

Medication adherence is one of a constellation of self-care behaviors (i.e., adherence to
treatment regimens, symptom monitoring and symptom management) that can improve HF
outcomes. Medication nonadherence is defined as doses not taken or taken incorrectly that
jeopardize the therapeutic outcome (Nichols-English & Poirier, 2000). Nonadherence is
estimated at 40% to 60% in patients with HF (Wu, Moser, Lennie, & Burkhart, 2008). This
is particularly concerning because medication adherence has been shown to decrease
hospitalization (Riegel & Knafl, 2013), decrease the healthcare costs associated with HF
(Wald & Law, 2003), and improve survival (Wu, Moser, Chung, & Lennie, 2008a).

Author Manuscript

In an analysis of Medicare patients with HF, Zhang and Baik (2014) found that in
comparison to White patients, ethnic minority populations, including Black and Hispanic
patients, were more likely to be nonadherent to common HF medications (i.e., beta-blockers,
angiotensin-converting enzyme [ACE] inhibitors, and diuretics), which helps to explain their
increased readmission rates, longer hospital stays and increased mortality (Bagchi, Esposito,
Kim, Verdier, & Bencio, 2007; Wu, Moser, Chung, et al., 2008a).

Predictors of Nonadherence
The reason for differences in medication adherence among White and Black patients with
HF is not entirely clear. Predictors of medication nonadherence include socioeconomic
factors (e.g., income), individual-level factors (e.g., race/ethnicity, age, social support),
condition-related factors (e.g., comorbid conditions, depression), and provider- or healthcare
system-related factors (e.g., provider satisfaction, access; Sabate, 2003). Other reasons
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include forgetfulness (Riegel et al., 2012), perceived lack of benefit (Wu, Moser, Chung, &
Lennie, 2008b), and cost (Van der Wal & Jaarsma, 2008). Whether the influence of these
factors differs between White and Black patients with HF has not been explored.

Research to Date

Author Manuscript

We have conducted a series of studies exploring predictors of medication adherence in HF
patients. In the first two analyses, we used the World Health Organization dimensions of
adherence (socioeconomic, condition, therapy, patient, and healthcare system) to focus our
exploration of contributors to nonadherence (Riegel & Knafl, 2013; Riegel et al., 2012). In
the third analysis, we tested a wide range of clinical and patient-related variables
(demographic, social support, self-care, symptoms, and cognition) to avoid omitted variable
bias (Knafl & Riegel, 2014). In a subsequent study we found that Blacks had poorer
medication adherence than Whites (Dickson, Knafl, & Riegel, 2015). Therefore, we sought
to examine how predictors of medication nonadherence differ between White and Black
patients with HF in order to understand where to focus future interventions aimed at
improving medication adherence in those patients most vulnerable to poor HF outcomes.
Specifically, this study addressed these research questions:
1.

What factors put Black patients with HF at risk for medication nonadherence?

2.

What factors put White patients with HF at risk for medication nonadherence?

3.

How do these factors differ among Black and White patients with HF?

Methods
Author Manuscript

Parent Study
The methods used in the larger study have been described in other reports (Riegel & Knafl,
2013; Riegel et al., 2012). In brief, between 2007 and 2009, 280 adults living in the
northeastern United States with chronic HF were enrolled into a prospective cohort
comparison study. A total of 242 adults completed the study.

Author Manuscript

Cohorts were purposefully varied on the dimensions of cognition, tested with a
neuropsychological battery (Riegel et al., 2011) and daytime sleepiness assessed with the
Epworth Sleepiness Scale (Johns, 1992). Inclusion criteria specified that participants have a
confirmed diagnosis of HF of any type, fluency in English, and visual, hearing and health
literacy sufficient to actively participate in all testing. All participants met a minimum level
of cognition screened with the Telephone Interview of Cognitive Status (TICS); anyone with
a score < 24 was excluded. Further exclusion criteria including major depression, renal
dialysis, recent history of serious drug or alcohol abuse, imminent death due to terminal
illness, and working at night because of the emphasis on exploring sleepiness as a predictor
of self-care.
The instruments were administered and other data were collected in a quiet setting in the
home by trained research assistants. Institutional Review Board approval was obtained for
the study and every participant provided written informed consent.
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Adherence—The Medication Event Monitoring System (MEMS™; MVW Switzerland
Ltd., Sion, Switzerland) attached to a bottle of medication was used to collect medication
adherence data objectively from individual patients. The device records the date and time of
all bottle openings. MEMS data were collected on one medication scheduled to be taken at a
fixed time, preferably more than once daily. Most patients were willing to use the device for
one of their cardiac medications (beta blocker 56.7%, angiotensin-converting enzyme
inhibitor 15.2%), but a wide variety of medicines was monitored. A single medication was
monitored based on the observation of Cramer et al (1995) that patients usually took doses
of all their medications simultaneously. That is, if a patient is likely to forget one medicine,
chances are that he will forget all of them.

Author Manuscript

Participants were fully informed that the MEMS device captured their medication-taking
behavior in a computer chip. They were instructed on how to integrate the device into their
daily routine, even if they routinely used a pill box. MEMS data were collected over the
entire 6months of the study and downloaded at 3 and 6 months. Participants kept a study
diary for the MEMS in which they could note openings that were accidental or for another
purpose (e.g. to fill the container). These deviations were corrected before analysis.
Demographic and clinical variables—Sociodemographic variables, including race,
were self-reported. Clinical characteristics such as left ventricular ejection fraction,
laboratory values, and the Charlson Comorbidity Index (Charlson, Pompei, Ales, &
MacKenzie, 1987) were abstracted from the medical record by registered nurses. Blood
pressure was measured during the home visit using calibrated equipment. Pulse rate was
measured at the same time.

Author Manuscript

Depression—Depression was measured using the Patient Health Questionnaire (PHQ-9;
Kroenke, Spitzer, & Williams, 2001), a reliable and well-validated measure used frequently
in HF studies (Masoudi et al., 2004; Sullivan, Newton, Hecht, Russo, & Spertus, 2004). The
PHQ-9 had a sensitivity of 88% and a specificity of 88% for detecting major depression
when a score of 10 was compared to professional interviews as the criterion standard
(Kroenke et al., 2001).

Author Manuscript

Heart failure self-care—Self-care was measured using the Self-Care of Heart Failure
Index (SCHFI V6.2), a 22- item measure of self-care maintenance, management, and
confidence (Riegel, Lee, Dickson, & Carlson, 2009). Construct validity was demonstrated in
a sample of 659 HF patients. When internal consistency was tested by factor score
determinacy, all coefficients were >.70, with moderate to high correlations over time in testretest reliability testing (Barbaranelli, Lee, Vellone, & Riegel, 2014).
Social support—Social support was measured using the Multidimensional Scale of
Perceived Social Support (MSPSS). The 12-item MSPSS measures perceived adequacy of
social support from three sources using a 7-point likert scale. Construct validity was
demonstrated in a sample of 275 adults and confirmed in subsequent populations (Zimet,
1988; Zimet, Dahlem, Zimet, & Farley, 1994). Factor analysis confirmed a three-subscale
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structure of the MSPSS: family, friends and significant others (Zimet et al., 1990). The
MSPSS has strong alpha coefficients in HF populations (.87 to .91; Dickson, Deatrick, &
Riegel, 2008; Dickson, McCarthy, Howe, Schipper, & Katz, 2013). In this study, Cronbach
alphas for the subscales were very strong (.92, .93 and .88); the total scale alpha was .90.

Author Manuscript

Compensatory activities—The Compensatory Activities Survey was investigatordesigned to assess methods used to compensate for feeling confused or forgetful.
Participants were asked to indicate how often over the past week they used the following
five compensatory activities identified from the published literature: 1) keep lists or notes to
yourself, 2) get help from your wife/husband, children, neighbor, or others, 3) associate
something you want to remember with something else that you already know or remember,
4) visualize the thing you want to remember, 5) repeat new things to yourself. An additional
question asked about other techniques used. Each item was scored never, rarely, sometimes,
often, frequently or always. For the final “other” activity, nothing else was an additional
choice. The number of items endorsed was used as the score. The Cronbach alpha for this
survey was .65.

Author Manuscript

Cognition—Cognition was assessed using a neuropsychological battery of four tests used
commonly in patients with HF (Alosco, Spitznagel, Josephson, Hughes, & Gunstad, 2015;
Miller et al., 2012) that measured attention, processing speed, working memory, and shortterm memory. The Digit Symbol Substitution Test (DSST) is a timed test in which numbers
are matched with different nonsense symbols. The DSST discriminates age cohorts (Joy et
al., 2003) and is sensitive to subtle neurocognitive impairment (Hinton-Bayre, Geffen, &
McFarland, 1997). A poor working memory slows performance and accuracy. The number
completed in 120 seconds, the number correctly matched, and percent correct were used in
analysis. Test developers reported test-retest reliability of 0.86 (Gregory, 1999).
The Probed Memory Recall (PMR) test is a free recall measure of verbal learning and
retention. Four word pairs are studied for 30 seconds. After a 10-minute delay, one word in
each pair (in a different order) is presented. The task is to recall all four of the paired words
within one minute. Recall of only two of four words suggests that memory is impaired
(Dinges, Kribbs, Bates, & Carlin, 1993).

Author Manuscript

The Trail Making Test is a widely used and sensitive measure of attention and cognitive
flexibility, a component of executive function (Reitan, 1955), and has shown strong testretest reliability (.86 to .94; Wagner, Helmreich, Dahmen, Lieb, & Tadic, 2011). In patients
with HF, the Trail Making Test has demonstrated relationships to areas of brain pathology as
assessed by magnetic resonance imaging (Serber et al., 2008). In the Trail Making Test Part
A, subjects connect randomly numbered and ordered circles, using a pencil, as fast as
possible in serial order. In Part B, on another worksheet, they are asked to connect the same
number of consecutively numbered and lettered circles by alternating between numbers and
letters.
The Letter Number Sequencing subtest of the Wechsler Adult Intelligence Scale—Third
Edition (WAIS III) is primarily a measure of auditory working memory and attention,
although it also measures executive function. In this task, participants sequentially order a
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series of numbers and letters that have been orally presented in a specified random order.
They must first remember the numbers and letters and then reorganize them into ascending
or alphabetical order. Slowed processing speed, inability to remember earlier responses, and
reduced capacity to ignore irrelevant information all contribute to decrements in
performance. The internal consistency coefficient is .82 (Silva, 2008) and test-retest
reliability is .75 (Alosco et al., 2015).
Data Analysis
For this analysis the variables were organized into six categories: 1) demographics (e.g., age,
gender), 2) social support (e.g., marital status, Multidimensional Scale of Perceived Social
Support score), 3) clinical (e.g., comorbidities, serum sodium), 4) self-care (e.g., Self-Care
of Heart Failure Index, HF knowledge), 5) symptoms (e.g., NYHA class, depression), and 6)
cognition (e.g., DSST, Compensatory Activities Survey).

Author Manuscript

Adaptive modeling of adherence outcome—In our first paper using the MEMS data,
standard summary measures of the MEMS data were used, for example, percentage of
prescribed doses that were taken (% PDT; Riegel et al., 2012). Subsequently, adaptive
modeling methods (Knafl et al., 2010) were used to analyze available MEMS data more
fully (Riegel & Knafl, 2013). These methods were used to identify individual-patient
adherence patterns represented by possibly nonlinear mean adherence and adherence
variability curves over time. The adherence patterns were normalized by prescribed rates so
that the ideal pattern had constant mean adherence of 1 and constant adherence variability of
0 (although no patients had adherence variability of 0). Then, these individual-patient
adherence patterns were clustered into adherence types or groups of participants with similar
adherence patterns.

Author Manuscript

Seven adherence types were identified, but hospitalization within 6 months was best
predicted by combining the seven types into the dichotomous predictor of poor adherence
(i.e., three of the clusters with adherence deteriorating to zero adherence or nearly zero over
time) versus better adherence (i.e., four clusters with moderate to high adherence over the
entire measurement period). This adaptively-determined dichotomized outcome served as
the nonadherence outcome for the analyses reported in this article.

Author Manuscript

Model development of predictors of nonadherence—Logistic regression models
for medication nonadherence were generated using adaptive modeling methods (Knafl et al.,
2010). These methods use k-fold likelihood cross-validation (LCV) scores to evaluate and
compare models, with larger LCV scores indicating better models. Observations are
separated into k disjoint subsets, called folds, using random numbers. For each fold,
parameter estimates for a given model are computed using the data in all the other folds.
These deleted parameter estimates are then used to compute likelihoods for the folds, which
are then normalized by the sample size and combined into the LCV score for the associated
model. For reported analyses, LCV scores are based on 10 folds and on likelihoods for
logistic regression models.
LCV scores for two models can be compared with LCV ratio tests, analogous to likelihood
ratio tests, but conducted using the percent decrease for the smaller LCV score compared to
Res Nurs Health. Author manuscript; available in PMC 2016 August 01.
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the larger LCV score. LCV-based comparisons provide more objective assessments of
effects of individual predictors in comparison to significance tests of slopes for those
predictors. Moreover, they can be more conservative, identifying predictors as having
insubstantial effects when the associated test for zero slope is significant (see the Results for
examples), and so are similar in effect to multiple comparisons procedures.

Author Manuscript

Each data set has an associated cutoff for a substantial (distinct or significant) percent
decrease in LCV scores that depends on the number of observations in that data set. A
percent decrease greater than this cutoff indicates that the model with the smaller LCV score
is improved upon substantially by the model with the larger LCV score. When the model
with the smaller LCV score is simpler, it is preferable. A percent decrease less than or equal
to this cutoff indicates that the model with the smaller LCV score is a competitive
alternative to the model with the larger LCV score. For example, when the constant model is
compared to a model based on a single risk factor, a percent decrease in LCV scores less
than the cutoff for the data indicates that this risk factor has an insubstantial effect on
medication nonadherence. In the present analysis, cutoffs for a substantial percent decrease
in the LCV scores were 3.00% for Blacks and 1.28% for Whites.
Separate analyses for the Black and White subgroups were chosen over moderation analyses
of the combined data. When x is a possible predictor, a moderation analysis would include
both the predictor x and its interaction with being Black. This approach assumes that the
predictor has an effect for Whites that differs from the effect for Blacks. However, it is
possible that x has an effect only for Blacks and not for Whites, or vice versa. Subgroup
analyses were chosen because they allowed for different predictors for Blacks and Whites.

Author Manuscript

Dichotomous risk factors for medication nonadherence were identified separately for Black
and White participants using the following process: 1) Bivariate models were used to
identify risk factors with an odds ratio (OR) > 1 for medication nonadherence. 2) Identified
risk factors with significant (I<.05) slopes were combined adaptively into a multiple risk
factors model. 3) The adaptive multiple risk factors model was used to generate the
associated risk index model for medication nonadherence, based on the count of that
model’s risk factors. Interactions between risk factors were not considered in these subgroup
analyses (as they were in analyses of the full data; Knafl & Riegel, 2014) because
meaningful interaction results were unlikely given the modest subgroup sample sizes.

Author Manuscript

In step 1, categorical variables were used unchanged. In subsequent analysis steps, the
predictors, whether ordinal or continuous, were dichotomized as follows. A predictor’s
observed values were split into two sets, using each of those observed values as a threshold
for low versus high ranges of values. Only cases with at least 10% of the observations in
each range of values were considered. The selected threshold was the one generating the
best LCV score for predicting medication nonadherence. Cases with values producing an OR
>1 were treated as having the risk factor. Observations with missing values were
conservatively assigned to the non-risk factor range of values. Information can be lost when
a predictor is categorized into two levels, so LCV scores for categorized and uncategorized
predictors were compared. Comparisons were limited to predictors with no missing values,
because the compared LCV scores would have been computed for the same set of data.
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In step 2, a model was selected using the adaptive modeling process of Knafl et al. (2010).
Risk factors under consideration for inclusion in the model were added systematically to the
model using LCV scores to decide which risk factor to add next. Then this expanded model
was contracted, removing any extraneous risk factors. LCV ratio tests were used to decide
whether to continue contracting the model or stop the contraction.
In step 3, the count of the number of risk factors in the adaptively generated multiple risk
factors model was used as a risk index variable for predicting medication nonadherence.

Results
Sample

Author Manuscript

Usable MEMS data were available for 218 (90.1%) of the 242 participants who completed
the parent study. Of these 218 participants with MEMS data, 149 (68.3%) were White and
69 (31.7%) were non-White. Of those who were non-White, the vast majority was Black (63
or 91.3% out of 69); 4 were Hispanic and 2 were American Indian. Therefore, we focused
our analysis on the 212 White and Black participants.
Table 1 provides a comparison of Blacks and Whites on selected demographic
characteristics. Black participants were significantly more likely than White participants to
be retired, unemployed, or disabled, to report insufficient income, to have government or no
insurance, and to be single, divorced, separated, or widowed. Black participants had
significantly fewer years of education on average.

Author Manuscript

Table 2 provides a comparison of Blacks and Whites on selected clinical variables. Blacks
were significantly more likely to perceive their general health as poor and to have severely
limited functioning (NYHA functional class IV). Black participants had significantly more
comorbid conditions, took more medications, and took more doses of those medications
each day.

Author Manuscript

Low adherence based on MEMS is often defined as percent doses taken (% PDT) < 88%
(Wu et al., 2009). A total of 87 (41.0%) of the 212 participants had % PDT ≥ 88%, with 27
(28.7%) of these hospitalized in 6 months. The remaining 63 (29.7%) participants had %
PDT < 88%, and better adherence as determined adaptively, with 18 (28.6%) hospitalized in
6 months. A total of 62 (29.2%) of the 212 participants had poor adaptively measured
adherence, with 35 of these 62 (56.5%) of these hospitalized within six months. All these
participants also had poor adherence when traditionally measured as % PDT < 88%. The
hospitalization rates were almost the same for these latter two groups, demonstrating that
poor adherence determined adaptively is a more sensitive indicator than % PDT < 88%.
Consequently, % PDT was not considered in further analyses.
When examined using %PDT, Black participants were significantly more likely than White
participants to have this type of poor adherence (p=.001; 76.2% vs. 51.7%). However, when
poor adherence was determined adaptively, Black participants were no more likely than
Whites to have poor adherence (p=.395; 33.3% vs. 27.5%).
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Table 3 contains results for individual risk factor analyses of medication nonadherence (as
determined adaptively) for Black participants. There were 16 individually significant (p≤.
05) risk factors. The constant model generated a substantial percent decrease in the LCV
scores (greater than the previously determined cutoff of 3.00%) for 10 of these 16 risk
factors (LCV scores not reported), indicating that LCV ratio tests can generate conservative
results. The individual risk factor model based on more comorbidities had the best LCV
score of 0.54732 among all the individual risk factor models of Table 3.

Author Manuscript

Of the 15 risk factors of Table 3, 10 could be analyzed as continuous or ordinal predictors
(not counting living alone) as well as risk-factor categories and had no missing values, so
these 10 risk-factor models could be compared to models linear in the associated predictors,
to assess the impact of categorizing these variables. For all 10 of these predictors, the
categorized risk-factor model generated the better LCV score than the associated linearpredictor model. Moreover, for five of these predictors (blood urea nitrogen, creatinine,
serum sodium, PHQ total score, and DSST score), the linear-predictor model generated a
substantially lower percent decrease in the LCV score. This finding indicated that adaptively
categorizing these variables into two-level risk factors provided substantially better
predictions of poor adherence than that obtained with standard linear-predictor modeling.

Author Manuscript

Table 4 contains results for the adaptive multiple risk factors model based on the 16
significant individual risk factors of Table 3. This model included four risk factors jointly
predicting poor adherence: more comorbidities, lower serum sodium, higher systolic blood
pressure, and fewer methods of compensating for forgetfulness. This model had a LCV
score of 0.61437, which was a substantial improvement over the individual risk factor model
with the best LCV, with a substantial percent decrease of 10.91%. Consequently, the
multiple risk factors model for Black participants provided a substantial improvement over
all the individual risk factor models. This model had a c-index (the same as the area under
the receiver-operating characteristics [ROC] curve) of 0.86, which is considered excellent
discrimination (Hosmer & Lemeshow, 2000). The Nagelkerke R2 was 50.4%.
Numbers of risk factors from the multiple risk factor model for the 63 Black patients ranged
from 0 to 4, with 15 (23.8%) patients having none of the risk factors, 27 (42.9%) patients
having 1, 17 (27.0%) having 2, 3 (4.8%) patients having 3, and 1 (1.6%) patient having all 4
risk factors. For the 15 patients with 0 risk factors, none were nonadherent; for the 27
patients with 1 risk factor, 22.2% were nonadherent; for the 17 patients with 2 risk factors,
64.7% were nonadherent; for the 4 patients with 3 or 4 risk factors, 100% were nonadherent
to the medication regimen.

Author Manuscript

To assess the possibility of collinearity between these four risk factors, logistic regression
models were computed predicting each of them as a function of the other three. The largest
Nagelkerke R2 value for these models was 2.2%. Thus, collinearity was not a problem for
the multiple risk factors model.
When the number of these 4 risk factors, treated as a risk index, was used as a single
predictor of nonadherence, this risk index model had a LCV score of 0.64523 and improved
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substantially on the multiple risk factors model, with a percent decrease in the LCV score of
4.78%. The c-index for this risk index model was also excellent at .85. The estimated OR for
medication nonadherence with each unit increase in the risk index count variable was 9.34
(95% CI 3.04 to 28.7; p<.001). That is, the odds of nonadherence increased by 9.34 times
with each additional risk factor.
Risk Factors for Medication Nonadherence for White Participants
Table 5 contains results for individual risk factor analyses of medication nonadherence for
White participants. There were 5 significant (p≤.05) individual risk factors (age,
comorbidities, months since HF diagnosis, total medication doses, cognition). The constant
model generated a substantial percent decrease in the LCV scores (greater than the cutoff of
1.28% for the White data) for 2 (40.0%) of these 5 risk factors (LCV scores not reported),
indicating once again that LCV ratio tests can generate conservative results.

Author Manuscript

Of the five risk factors of Table 5 based on continuous or ordinal predictors, three of them
had no missing values and could be compared to categorized risk factors. In all three cases,
the risk-factor model generated the better LCV score than the associated linear-predictor
model. For two (66.7%) of these predictors (age and TMTB score), the linear-predictor
model generated a substantially lower percent decrease in the LCV score, indicating that
adaptively categorizing these variables into two-level risk factors provided substantially
better predictions of poor adherence than was obtainable through standard linear-predictor
modeling.

Author Manuscript

The adaptive multiple risk factors model based on the five individually significant risk
factors of Table 5 identified only one risk factor: older age, which was the individual risk
factor model with the best LCV score of 0.56240 among all the individual risk factor
models. With only one risk factor, collinearity or a risk index model could not be
considered. The c-index for this singleton predictor model was .62, less than the cutoff of .
70 for acceptable discrimination (Hosmer & Lemeshow, 2000). The Nagelkerke R2 was
7.4%.

Discussion

Author Manuscript

Although others have reported differences in medication adherence by race/ethnicity or
identified the predictors of medication adherence among patients with HF in general, this
analysis is the first, to our knowledge, to differentiate the predictors of adherence by racial
group. Our findings that Blacks have more and different risk factors for poor medication
adherence is important because it provides specific guidance on where to focus interventions
aimed at improving medication adherence and related HF outcomes. We found that Blacks
had four risk factors that jointly predicted nonadherence (more comorbidities, lower serum
sodium, higher systolic blood pressure, and use of fewer activities compensating for
forgetfulness). Among White participants, only one risk factor (older age) explained the
individual effects of the other four, which is consistent with evidence that medication
nonadherence is common in the elderly (MacLaughlin et al., 2005).
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Comorbidity was identified as one of the four major risk factors among Blacks. Comorbidity
is extremely common in patients with HF (Braunstein et al., 2003) and adds complexity to
the medication regimen required of patients, in part due to the number of medications, drug
interactions, and side effects (Mastromarino et al., 2014). Multiple chronic conditions have
been shown to complicate self-care when patient care is fragmented (Dickson, Buck, &
Riegel, 2011). When faced with uncertainty about medication or unpleasant medication side
effects, patients with HF described the influence of self-efficacy on their daily self-care,
including decisions about which medications to take (Dickson, Buck, & Riegel, 2013).
Patients with multiple chronic conditions also experience more functional limitations that
make daily activities difficult, such as traveling to pick up medicines, remembering to take
them, and symptom recognition and management (Bakas, Pressler, Johnson, Nauser, &
Shaneyfelt, 2006). Because medication adherence is essential to HF outcomes (Riegel &
Knafl, 2013; Wu, Moser, Chung, et al., 2008a), our results suggest that Blacks may be more
vulnerable to the burden of multiple chronic conditions than Whites. Focused efforts to
integrate care and interventions to facilitate medication adherence are essential.
In Whites both comorbidity and cognition were individual determinants of nonadherence,
but their influence on adherence was explained away by older age in the final analysis. That
is, in Whites, nonadherence was related to age in a strong enough way that the effects of
comorbidity and cognition on adherence were no longer of substance. This finding was
surprising to us because it suggests that there is an element of aging itself, beyond
comorbidity and cognition, that is influencing nonadherence. Further research is needed to
determine the aspects of aging that are associated with medication nonadherence.

Author Manuscript

A lower level of serum sodium was a predictor of nonadherence in Blacks. At a cut-point of
≤ 139 meq/L, these serum sodium levels did not qualify as true hyponatremia. However,
because fluid retention stimulates atrial natriuretic peptide secretion and the loss of sodium,
a lower level of serum sodium is an indicator of the severity of cardiac dysfunction
(Gheorghiade et al., 2007). Thus, these results suggest that either the sicker Black patients
are those who are most likely to be nonadherent, or those who are nonadherent are most
likely to become sicker. To the best of our knowledge, this is the first study to demonstrate a
relationship between serum sodium and poor medication adherence.
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Interestingly, higher systolic BP was one of the four joint predictors of poor medication
adherence in Blacks but not in Whites. Previously we reported that Blacks were more likely
than Whites to have hypertension and to be prescribed isosorbide dinitrate and diuretics
(Dickson, Knafl, & Riegel, 2015). Guidelines recommend that the pharmacologic regimen
for patients with HF include angiotensin-converting-enzyme (ACE) inhibitors, beta blockers
and angiotensin receptor blockers (Yancy et al., 2013), all medications that lower BP. In
fact, poor blood pressure control is commonly blamed on medication nonadherence (Hayen,
Bell, Glasziou, Neal, & Irwig, 2010), and elevated systolic BP is associated with poor
medication adherence (Braverman & Dedier, 2009; Knafl, Schoenthaler, & Ogedegbe,
2012). Therefore, our finding that systolic BP is higher among Blacks may be a consequence
of poor medication adherence rather than a cause of nonadherence.
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The final factor significantly associated with nonadherence in Blacks was the use of fewer
methods to compensate for feeling confused or forgetful. We used a new measure of the
methods used by patients to compensate for such feelings. Other researchers have found that
older adults use internal and external strategies to remember to take their medications
including visual cues, consistent routines and physical objects (e.g., pill boxes; Gould,
McDonald-Miszczak, & King, 1997). Such compensatory strategies were associated with
higher education, more medications, and self-efficacy to take medications, but differences
by racial group were not explored (Boron, Rogers, & Fisk, 2013). Our finding that lack of
such methods was a significant risk factor for Blacks requires further exploration. How
individuals develop or adapt such methods, especially related to medication adherence, may
help inform future interventions.
Limitations

Author Manuscript
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Interactions were not considered because subgroup sample sizes were unlikely to be large
enough for interaction analysis. Further, our sample was English-speaking and fairly welleducated. Further research is needed in an adequately powered sample of persons of color
that includes non-English-speaking individuals and those with low literacy, groups which
were not adequately represented in the present study. In this study, measurement of
adherence was limited to one medication, and new data suggest that some subtle differences
exist in the adherence to various HF medicines (Viana et al., 2014). These data were
collected before this article was published, but future studies should monitor a single drug
class in all participants or preferably all the major drugs in the regimen. A strength of the
study was the use of objective measures of medication adherence using the MEMS rather
than relying on self-report or pharmacy data to calculate medication adherence. Self-report
has been shown to be unreliable, so our method of measuring medication adherence
strengthens our conclusions.
Conclusions

Author Manuscript

Although similar patterns of nonadherence have been found by others (Zhang & Baik, 2014)
our findings suggest that the issue of medication adherence is exceedingly complex for
many persons with HF, especially Blacks. Many of these patients were taking complex
medication regimens, with substantial numbers of medications. An individualized approach
may be needed in order to address the health disparities associated with medication
nonadherence. Specifically, clinicians should be sensitive to those factors (e.g., multiple
comorbid conditions) that may place ethnic minorities at increased risk for poor adherence.
Further research is needed to develop and test interventions that help Black patients with HF
to manage multiple medications required by multiple chronic conditions. These results also
reinforce the need to address methods of compensating for forgetfulness when teaching
Blacks about their medication regimens.
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13.0 (2.2)

61.7 (10.5)

Mean (SD)

102 (68.5)

47 (31.5)

75 (50.3)

74 (49.7)

137 (91.9)

12 (8.1)

51 (34.2)

98 (65.8)

48 (25.5)

38 (25.5)

63 (42.3)

n (%)

14.5 (3.1)

63.4 (12.0)

Mean (SD)

White (n=149)

.001

.321

<.001

.013

<.001

.449

.025

Only 2 (0.9%) of the 212 participants had no insurance, so they were combined with participants with government insurance.

b

Using χ2 or t test for differences between Blacks and Whites as appropriate.

a

Note. HMO= health maintenance organization; SD= standard deviation.

30–89

Years of education

23 (36.5)

20 (31.7)

Commercial or HMO
40 (63.5)

43 (68.3)

Government or noneb

Married or partnered

40 (63.5)

Have enough or more

Single, divorced, separated, or widowed

23 (36.5)

25 (39.7)

Do not have enough

Female

Age

Marital status

Insurance

Income

38 (60.3)

Male

9 (14.3)

Unemployed or disabled
Employed (full or part time)

22 (34.9)

Retired

Employment status

Gender

32 (50.8)

Categories or Observed Range

Variable

n (%)

Black (n=63)
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0–9
5–80
0–508
2–25
4–29

Ejection fraction

Months since heart failure diagnosis

Total medications

Total doses (medications)

9.5 (3.9)

11.0d (3.4)
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n = 53

n = 136

e

d

n = 61

c

n = 62

b

Using χ2 or t test for differences between Blacks and Whites as appropriate.

a

12.5 (5.5)

76.1e (80.9)

75.0c (62.9)

15.1 (5.4)

35.9 (16.5)

35.5b (19.2)

2.6 (1.6)
2.8 (2.1)

133 (89.3)

16 (10.7)

140 (94.0)

9 (6.0)

138 (92.6)

11 (7.4)

57 (38.3)

92 (61.7)

Mean (SD)

White (n=149)

3.7 (1.9)

3.0 (2.0)

Mean (SD)

Note. MEMS= Medication Event Monitoring System; NYHA= New York Heart Association; SD= standard deviation.

1–11

39 (61.9)

Number of comorbidities

24 (38.1)

I–III

Fair to excellent
IV

8 (12.7)
55 (87.3)

Poor

50 (79.4)

Fair to excellent

Charlson total

NYHA class

Health compared to a year ago

13 (20.6)

Poor

24 (38.1)

1

General health perception

39 (61.9)

2–3

Prescribed medication rate medication controlled by MEMS

n (%)

Black (n=63)
Categories or Observed range

Variable
n (%)
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.003

.009
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.002

.099

<.001

.104

0.005

.983
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≤ 80 (vs. > 80 or missing)
≥ 39
≥4
≥6
≥ 2.3
≤ 140 (vs. > 140 or missing)
≥ 135 (vs. < 135 or missing)

MSPSS Score

Blood urea nitrogenb

Charlson total

Number of comorbiditiesc

Creatinineb

Serum sodium

Systolic blood pressure

≥9
≤7
≤ 29
≤ 30
≥ 77
≥ 201 (vs. < 201 or missing)

PHQ totald

CAS score

DSST score

TICS score

TMTA scored

TMTB scorec

Symptoms

Cognition

9 (14.3)

9 (14.3)

21 (33.3)

11 (17.5)

21 (33.3)

9 (14.3)

43 (68.3)

13 (20.6)

40 (63.5)

8 (12.7)

9 (14.3)

18 (28.6)

8 (12.7)

46 (73.0)

21 (33.3)

11 (17.5)

n (%)a

10.0

5.20

3.19

4.75

4.89

5.20

4.08

4.56

5.46

8.00

10.0

5.50

8.00

5.28

3.52

4.75

OR

.007

.032

.050

.026

.006

.032

.044

.021

.015

.017

.007

.005

.017

.040

.027

.026

p

1.85–53.9

1.15–23.5

1.00–10.1

1.20–18.7

1.57–15.2

1.15–23.5

1.04–16.0

1.26–16.4

1.39–21.3

1.45–44.1

1.85–53.9

1.69–17.9

1.45–44.1

1.08–25.8

1.16–10.7

1.28–18.7

95% CI
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Although the estimates are the same for these two variables, they correspond to different sets of participants.

d

Although the estimates are the same for these two variables, they correspond to different sets of participants.

c

The estimates are the same for these two variables because they correspond to same set of participants.

Out of 63 Black participants with Medication Event Monitoring System data.

b

a

Note. OR= odds ratio, CI= confidence interval, CAS= Compensatory Activities Score; DSST= Digit Symbol Substitution Test, MSPSS= Multidimensional Scale of Perceived Social Support; PHQ= Patient
Health Questionnaire; SCHFI= Self-Care of Heart Failure Index; TICS= Telephone Interview for Cognitive Status; TMTA= Trail Making Test – A; TMTB= Trail Making Test – B.

≤ 72 (vs. > 72 or missing)

SCHFI maintenance

Self-care

Clinical

yes

Live alone

Social support

≥ 74

Age

Demographics

Risk Factor

Variable

Variable type

Risk Factor Models for Medication Nonadherence in Black Participants with Heart Failure that were Significant in Bivariate Analyses

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript
≤7

21 (33.3)

13 (20.6)

36 (52.2)

9 (14.3)

n in Risk Group (%)a

Out of 63 Black participants with Medication Event Monitoring System data.

a

Note. CAS = Compensatory Activities Score; OR = odds ratio; CI = confidence interval.

CAS score

Cognition

Systolic blood pressure

–

Serum sodium

–

≥ 135

Comorbidities

Clinical

Symptom

≤ 139

–

Social support

Self-care

≥6

–

Demographic

Risk Factor

Variable

Variable Type

7.21

10.8

8.2

11.9

OR

.025

.008

.023

.009

p

1.29–4.04

1.89–62.3

1.34–50.5

1.86–76.7

95% CI

Multiple Risk Factors Model of Medication Nonadherence in Black Participants with Heart Failure

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript

TMTB score

Cognition

≥ 93

Out of 149 White participants with Medication Event Monitoring System data.

a

Note. CI = confidence interval; OR = odds ratio; TMTB = Trail Making Test – B.

–

Total doses (medication)

–

≥ 11 (vs. < 11 or missing)

Months since heart failure diagnosis

Symptoms

≥ 153 (vs. < 153 or missing)

Comorbidities

Clinical

Self-care

≥4

–

Social support

≥ 61

Age

Demographics

Risk Factor

Variable

Variable Type

66 (44.3)

83 (55.7)

19 (12.8)

50 (33.6)

94 (63.1)

n (%)a

2.22

2.42

2.76

2.15

3.18

OR

.033

.025

.044

.044

.009

p

1.07–4.61

1.12–5.23

1.03–7.38

1.02–4.51

1.34–7.52

95% CI

Risk Factor Models for Medication Nonadherence in White Participants with Heart Failure that were Significant in Bivariate Analyses

Author Manuscript
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